Advertisement

Search Results for "Prostate Replacement"

05:25 EDT 24th May 2013 | BioPortfolio

Original Source: Androgen Replacement Therapy After Prostate Cancer Treatment.

Historically, testosterone supplementation has been avoided in men with a history of prostate cancer because of concern about prostate cancer progression or recurrence. However, recently published data suggest that this concern may not be well founded. The recurring presence of prostate-specific antigen in men with hypogonadism being treated with testosterone after prostatectomy is far less than the expected natural recurrence rate of the disease. There are many theories (including the prostate saturation t...

Matching Channels

Prostate Mab

Renal Replacement Therapy

Prostate biopsy

Prostate Abscess

Prostate Cancer

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Matching News

Testosterone Replacement Therapy in Prostate Cancer

What are the effects of testosterone replacement therapy in hypogonadal men who underwent radiation treatment for prostate cancer? International Journal of Impotence Research

Viewpoints: Insuring medical treatments are well researched; GOP Govs reluctance on exchanges may backfire

By 1990, many doctors were recommending hormone replacement therapy to healthy middle-aged women and P.S.A. screening for prostate cancer to older men. Both interventions had become standard medical p...

High Testosterone Levels Can Speed Up Prostate Cancer

The Financial Express reported that elderly men with higher levels of testosterone, including those who undergo hormone replacement therapy, are at an increased risk for prostate cancer, according to...

Testosterone therapy does not up prostate cancer incidence

(HealthDay) -- Testosterone replacement therapy (TRT) appears to be safe and does not increase the incidence of prostate cancer, according to a study published online June 6 in The Journal of Sexual M...

More testosterone increases prostate cancer risk in older men: study

(Medical Xpress) -- Older men - those in their 70s and 80s - with higher levels of testosterone, including those who undergo hormone replacement therapy, are at an increased risk of prostate cancer, a...

Testosterone replacement therapy in the setting of prostate cancer treated with radiation

Skin Patch Shows Promise Against Prostate Cancer

Delivering oestrogen through skin patches may offer a safer and easier way to treat prostate cancer than current hormone therapies, says new research from the UK. The study, published online in Lance...

AstraZeneca launches prostate cancer app

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the first PSA testing app and there are also other applications with the ability to commun...

Matching PubMed Articles

Testosterone Replacement Therapy and Prostate Health.

There is an emerging evolution in the understanding of the relationship between the prostate and testosterone. It has long been generally believed that with testosterone replacement therapy (TRT), inc...

Androgen Replacement Therapy After Prostate Cancer Treatment.

Historically, testosterone supplementation has been avoided in men with a history of prostate cancer because of concern about prostate cancer progression or recurrence. However, recently published dat...

Castration- and Aging-induced Changes in the Expression of Zinc Transporter and Metallothionein in Rat Prostate.

Prostate tissue contains high concentrations of zinc. Zinc content in the prostate gland changes in prostatic disease such as benign prostate hyperplasia and prostate cancer, which occur more frequent...

Correlation Between Serum Prostate-specific Antigen and Cancer Volume in Prostate Glands of Different Sizes.

OBJECTIVES: To further evaluate the relationship of prostate-specific antigen (PSA) with prostate size and tumor volume in a contemporary surgical series. Although early studies showed a strong correl...

Secondary squamous cell prostate cancer after prostate brachytherapy treatment.

Abstract This report describes the case of a patient with prostate cancerat the age of 59 years, who was treated by interstitial prostate brachytherapy with iodine-125 seeds. Ten years later, he devel...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement